Remdesivir, hydroxychloroquine did not cut hospital stay or mortality in COVID-19 patients: WHO

Gilead Sciences Inc`s remdesivir had little or no effect on COVID-19 patients` length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.